[1]
Lau, M.-F. et al. 2018. Rosiglitazone diminishes the high-glucose-induced modulation of 5-fluorouracil cytotoxicity in colorectal cancer cells. EXCLI Journal. 17, (Feb. 2018), 186–199. DOI:https://doi.org/10.17179/excli2018-1011.